dolescents and young adults (AYAs) with cancer, as well as survivors, have noted that discussing treatment risks associated with fertility and fertility preservation (FP) options with the oncology treatment team is important (Gorman et al., 2014; Gupta, Edelstein, Albert-Green, & D'Agostino, 2013; Ruddy et al., 2014) . Various professional associations have recommended that, because of the potential negative impact of chemotherapy or radiation therapy on reproductive functioning, the risks of treatment to fertility and FP options be communicated to all patients of reproductive age, regardless of diagnosis or treatment plan, prior to the onset of treatment (Hayes & Bubley, 2015; Sathyapalan & Dixit, 2012) . However, what remains unclear is how these discus-sions are initiated, whether these discussions occur with all patients, and which members of the oncology team are responsible for communicating with patients about these risks and available options.
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